USPTO serial 99734795
BIOMATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAYES, LAURIE ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with BIOMATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Tetreault
Mark Tetreault DEKA Research and Development340 Commercial StreetManchester, NH 03101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Biomanufacturing devices for engineering of three-dimensional tissues, organs, and autologous cell samples, namely, 3D bioprinters; Fabrication devices for rejuvenation of tissues, organs, autologous cell samples, namely, tissue rejuvenation devices in the nature of bioprinters | ACTIVE | Nov 7, 2023 |
| 009 | Automated and semi-automated cell culture apparatus for laboratory use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Laboratory equipment and supplies, namely, incubators for cell culturing, cell therapy, tissue manufacturing and organ manufacturing and electronic monitors for monitoring cell culture incubators; Biochips for the production of three-dimensional living tissues, organs and autologous cell samples for research or scientific purposes; Bioreactors for cell culturing for laboratory use; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers for the purpose of laboratory research; Automated and semi-automated medical equipment for the preparation of autologous and allogeneic biological cell therapies for medical purposes, namely, a fully integrated system composed primarily of computers, electronic sensors, and monitors, plastic tubing, syringes, and pumps, and metal containers, bottles, and heating plates for use in the creation of biological cell therapies, organs, tissues and autologous cell samples for medical purposes; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of medical and scientific research | ACTIVE | Nov 7, 2023 |
| 010 | Automated and semi-automated cell culture apparatus for medical use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Medical devices, namely, electromechanical fluidic instruments, and cell culture chambers, which process complex human body fluids for the purpose of separating human cell culture samples, and separating fluids; Medical instruments for processing of human body fluids in the nature of human cell samples, blood, and plasma, and the isolation and concentration of components thereof for the purpose of treating degenerative diseases, and chronic diseases; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of therapeutic regenerative medical treatment, blood transfusions, and cell transfusions | ACTIVE | Nov 7, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DEKA Research and Development Corp.
- Other trademarks owned by DEKA Research and Development Corp.
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named BIOMATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 29, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 23, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 29, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 10, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 31, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 31, 2026 | NWAP | NEW APPLICATION ENTERED | — |